FindTrial
Sign In

Assessment of Artery and Veins of Liver by Transesophageal Echocardiography (TEE) in Living Donor Liver Recipients

Evaluation of Hepatic Vasculature by Transesophageal Echocardiography (TEE) in Patients Undergoing Living Donor Liver Transplantation: A Prospective Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/098718
Enrollment
30
Registered
2025-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K703- Alcoholic cirrhosis of liver Health Condition 2: K739- Chronic hepatitis, unspecified Health Condition 3: K746- Other and unspecified cirrhosis ofliver

Interventions

Intervention1: Nil: Nil

Sponsors

Institute of Liver and Biliary Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patents undergoing living donor liver transplantation

Exclusion criteria

Exclusion criteria: Patients having contraindications to TEE placement: High risk esophageal varices, Esophageal varices grade more than 2, History of recent upper abdominal bleed within 1 month, History of recent variceal ligation within 1 month, Gastric antral variceal ectasia, Gastric polyp, Coagulopathy, Esophageal strictures, Esophageal tumor, and Esophageal diverticula, History of esophageal surgery, Esophagitis.

Design outcomes

Primary

MeasureTime frame
To evaluate portal vein, hepatic vein and hepatic artery velocity by TEE in patients undergoing living donor liver transplantation.Timepoint: Baseline, After portal vein reperfusion, After hepatic artery reperfusion—

Secondary

MeasureTime frame
To evaluate portal vein flow by TEE in patients undergoing living donor liver transplantation.Timepoint: Baseline, After portal vein reperfusion, After hepatic artery reperfusion;To compare the portal vein, hepatic vein and hepatic artery velocity and waveform between TEE and intraoperative doppler.Timepoint: Baseline, After portal vein reperfusion, After hepatic artery reperfusion;To assess change in portal vein velocity after graft reperfusion.Timepoint: Baseline, After portal vein reperfusion, After hepatic artery reperfusion;To note any other significant findings in TEE.Timepoint: Baseline, After portal vein reperfusion, After hepatic artery reperfusion;To note any complications related to TEE.Timepoint: Baseline, After portal vein reperfusion, After hepatic artery reperfusion—

Countries

India

Contacts

Public ContactAbhishek Arya

Institute of Liver and Biliary Sciences

drsindwani25@gmail.com8728089898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026